Cancer

Category

OneOncology Partners with Genentech to Bring Personalized Cancer Research to Patients at Community Oncology Sites

The cancer research as a care option movement gains considerable momentum in the United States with the recent formation of a partnership between OneOncology, the national partnership of independent oncology practices, and Genentech, a member of the Roche Group (SIX:...

University of Louisville’s Brown Cancer Center Embraces Immuno-Oncology Developed at NCI: Some Patients See Dramatic Results

A 46 year-old man residing in the Louisville, Kentucky area was given about six months to live, according to a physician’s grim forecast. With stage four lung cancer that August, Tony Burton’s options for life narrowed but he sought out a second opinion with Dr. Jason...

Cancer Clinical Trials As-Care-Option Moves into Western North Carolina via Messino Cancer Centers & Sarah Cannon Research Institute Partnership

The clinical research as a care option movement advances with yet another important but not well publicized deal involving Messino Cancer Centers (MCC), a partner practice of American Oncology Network, LLC (AON) and the Sarah Cannon Research Institute, a global leader...

Southeast Nebraska Cancer Center Joints Elite NCI Cancer Networks to Offer State-of-Art Clinical Trials to Nebraskan Cancer Patients

The Southeast Nebraska Cancer Center (SNCC) brings the clinical research as a care option movement to Lincoln, Nebraska, and more generally the eastern regions of the state. By offering local patients with advanced oncologic and hematologic diagnoses comprehensive,...

SWOG Cancer Research Network Deepens Ties into Veterans Administration for More Clinical Research as a Care Option Access

SWOG Cancer Research Network and its charity, The Hope Foundation for Cancer Research, announced the award of two grants designed to give military veterans better access to cancer clinical trials. Under the VA Integration Support Program, U.S. Department of Veterans...

Pierre Fabre Initiates a “First in Human” Clinical Trial for an Innovative Monoclonal Antibody (W0180) Targeting the VISTA Checkpoint in Patients with Solid Tumors

Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre Fabre Medical Care...

Karmanos Cancer Institute Launches Diversity & Inclusion Committee & Participates in the Detroit Renaissance

With the move to precision medicine, especially in oncology, the inclusion of diverse populations in research and development can be a matter of life and death. Thought of another way, with ethnic minorities and others considered underrepresented experiencing cancer...

NCI Awards Funds to Dartmouth-Hitchcock’s Norris Cotton Cancer Center to Improve Rural Access to Cancer Clinical Trials

A newly awarded $820,000 grant from The National Cancer Institute (NCI) will allow a team of multi-disciplinary investigators to increase clinical trial awareness and participation for rural patients who make up almost half of the area served by Dartmouth and...

NCI Injects $111m into NYC’s Montefiore & Einstein to Prevent & Treat HIV-Associated Cancers

Modern medicine, often a near miracle, creates more challenges to solve. For instance, the adoption worldwide of antiretroviral therapies to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives. However, with this...

CodeBreak 100 Study: Sotorasib Zaps Lung & Colon Cancer Tumors in Majority of Participants

KRAS is a cancer gene has been studied for about 40 years, reports Memorial Sloan Kettering Cancer Center (MSKCC). It is known to be associated with a number of cancers such as about 25% of lung cancers and between 33% and 50% of colon and rectal cancers. Until...

Pin It on Pinterest